3933 — United Laboratories International Holdings Cashflow Statement
0.000.00%
- HK$24.60bn
- HK$21.27bn
- CNY13.76bn
- 37
- 58
- 81
- 64
Annual cashflow statement for United Laboratories International Holdings, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
C2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | — |
Source: | ARS | ARS | ARS | ARS | |
Standards: | HKAS | HKAS | HKAS | HKAS | — |
Status: | Final | Final | Final | Final | fx Preliminary |
Net Income/Starting Line | 882 | 1,203 | 2,007 | 3,344 | — |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 297 | 215 | 58.7 | -38.6 | — |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -226 | -495 | -587 | -1,432 | — |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Payable / Accrued Expenses | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 1,568 | 1,543 | 2,031 | 2,439 | — |
Capital Expenditures | -531 | -482 | -818 | -1,411 | — |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 698 | -105 | 224 | -146 | — |
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Change in Net Intangibles | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | 167 | -587 | -595 | -1,557 | — |
Financing Cash Flow Items | -123 | -41.3 | -33.7 | -42.3 | — |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -1,908 | -621 | -24.2 | -1,363 | — |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -168 | 334 | 1,412 | -481 | — |